Previous Article | Next Article 
Molecular and Cellular Biology, December 2001, p. 8592-8604, Vol. 21, No. 24
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.24.8592-8604.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Identification and Characterization of Thymus LIM
Protein: Targeted Disruption Reduces Thymus Cellularity
Jacqueline
Kirchner,
Katherine A.
Forbush, and
Michael J.
Bevan*
Howard Hughes Medical Institute and
Department of Immunology, University of Washington, Seattle,
Washington 98195
Received 16 July 2001/Returned for modification 28 August
2001/Accepted 18 September 2001
 |
ABSTRACT |
We have identified a novel LIM gene encoding the thymus LIM protein
(TLP), expressed specifically in the thymus in a subset of cortical
epithelial cells. TLP was identified as a gene product which is
upregulated in a thymus in which selection of T cells is occurring
(Rag
/
OT-1) compared to its expression in a
thymus in which selection is blocked at the CD4+
CD8+ stage of T-cell development (Rag
/
Tap
/
OT-1). TLP has an apparent molecular mass of 23 kDa and exists as two isomers (TLP-A and TLP-B), which are generated by
alternative splicing of the message. The sequences of TLP-A and TLP-B
are identical except for the C-terminal 19 or 20 amino acids. Based on
protein sequence alignment, TLP is most closely related to the
cysteine-rich proteins, a subclass of the family of LIM-only proteins.
In both medullary and cortical thymic epithelial cell lines transduced
with TLP, the protein localizes to the cytoplasm but does not appear to
be strongly associated with actin. In immunohistochemical studies, TLP
seems to be localized in a subset of epithelial cells in the cortex and
is most abundant near the corticomedullary junction. We generated mice
with a targeted disruption of the Tlp locus. In the absence
of TLP, thymocyte development and thymus architecture appear to be
normal but thymocyte cellularity is reduced by approximately 30%, with
a proportional reduction in each subpopulation.
 |
INTRODUCTION |
T-cell development requires many
interactions between thymocytes and thymic stromal cells. As thymocytes
develop, they begin as CD4
CD8
double-negative (DN) cells which
proliferate and rearrange their T-cell receptor (TCR) beta chain
genes. The DN thymocytes, which express a pre-TCR, progress to
CD4+ CD8+ double-positive
(DP) cells, which rearrange TCR alpha chain genes and express TCR. A
small percentage of the DP thymocytes are positively selected into the
CD4 single-positive (SP) or CD8 SP lineage. Fully mature SP cells then
emigrate to the periphery. Thymic stromal cells, a heterogeneous
population of cells including epithelial cells, fibroblasts, mesenchyme
cells, and the bone marrow-derived dendritic cells (DCs) and
macrophages, are involved at each step in T-cell development (reviewed
in references 4, 54, and 74). The DN-to-DP transition
requires cell-cell interactions between early precursor thymocytes and
both thymic epithelial cells (TECs) and fibroblasts (3,
57). In addition, cytokines that are necessary for the early
expansion of DN cells and at later thymocyte developmental stages are
provided by TECs (21, 46). For example, interleukin-7
(80) and stem cell factor (52) each
appear to have an important role in the proliferation of thymocytes
(29, 32, 49, 76). Positive selection of thymocytes is
mediated by cortical TECs (cTECs) expressing the major
histocompatibility complex (MHC)/peptide ligand for TCR (3, 63). cTECs are unique in this capacity, providing more than just the selecting ligand, since other cell types expressing the
ligand are unable to substitute for them (5, 16, 47). DCs
in the medulla and at the corticomedullary junction mediate negative
selection of thymocytes with too high an affinity for self peptide/MHC
ligand (44, 48, 53, 69). The medullary epithelium also
appears to play a role in negative selection but is less efficient than
DCs (26, 30, 65). The interactions between DP thymocytes
and thymic stromal cells are critical to ensure that a sufficient
T-cell repertoire with the appropriate degree of affinity for self develops.
TECs constitute the majority of thymic stromal cells and can be divided
into three main classes based upon location in the thymus: subcapsular,
cortical, and medullary. cTECs and medullary TECs (mTECs) are
phenotypically distinguishable from each other by morphology and
immunohistology using monoclonal antibodies (Abs) (reviewed in
reference 11). For example, 6C3, also known as BP-1,
stains only cTECs (1), while ERTR5 stains only mTECs (75). Within the cTEC population, there appears to be
further heterogeneity based on staining with several monoclonal Abs.
For example, 6C3 (1) and NLDC145 (42), also
known as DEC-205 (35), each stain only a subset of cTECs.
There appear to be at least two types of cTECs based on expression of
keratin 5 (K5) and K8 (39). The majority of cTECs express
K8 but not K5, while a minor subset express both. It is not clear
whether phenotypically different cTECs represent differentiated cell
types with specialized functions or cells undergoing different
responses to thymocytes in different microenvironments.
Much is known about the origins of TECs, but little is known about the
molecular mechanisms governing their development and differentiation
into functional cells. It is clear, however, that development of TECs
and organization of the thymus into cortex and medulla are dependent on
thymocyte development (reviewed in reference 62; 4,
54, 74). Development of mTECs and formation of an organized
medulla depend on the presence of 
TCR+
thymocytes, as seen in SCID (66, 67),
RAG
/
(51), and
TCR
/
(58, 60) mice. In
addition, there are data to suggest that the organization of the
medullary epithelium is influenced by signals from thymic vasculature
(6). The three-dimensional organization of a thymic cortex
into microenvironments capable of promoting T-cell development appears
to depend on progression of DN thymocytes from a
CD44+ CD25
phenotype to a
CD44
CD25+
phenotype (31, 73). At the molecular level, a
number of transcription factors, including whn, relB, Pax9, Hoxa3, and
Pax1, have been shown to play important roles in thymus organogenesis
and TEC development (13, 15, 55, 59, 68). For the most
part, however, the molecular mechanism for development of TECs is unknown.
LIM proteins are known to play a number of important roles in
development and differentiation (reviewed in reference
10). They are defined by the presence of a LIM domain,
which consists of two tandemly repeated zinc fingers with the following
consensus sequence:
CX2CX16-23HX2CX2CX2CX16-23CX2-3(C/H/D) (64). The LIM domain mediates protein-protein
interactions which are important for such processes as gene regulation
and cytoskeletal organization (10). One subclass of LIM
proteins, the LIM-only proteins, do not have a homeodomain. Among the
LIM-only proteins are the cysteine-rich proteins (CRPs). Three family
members have been identified in vertebrates: CRP1, CRP2, and
CRP3/muscle LIM protein (MLP) (8, 28, 33, 36, 43, 50, 56, 78, 79,
83). These three proteins are highly similar to each other in
sequence and structure but have distinct patterns of expression. Functionally, MLP has been shown to promote myogenesis (8) through its interaction with MyoD (40) and to be required
for normal cardiomyocyte cytoarchitecture and function
(9).
To identify novel genes involved in positive selection of thymocytes,
we performed PCR-based subtractive hybridization between a thymus in
which there was a high degree of positive selection and a thymus in
which selection is blocked at the DP stage of development
(37). Mice with highly selecting thymuses expressed a MHC
class I (MHC-I)-restricted transgenic TCR (OT-1) on a
RAG2
/
background. Thymocytes in these mice
are selected primarily into the CD8 lineage. Mice with nonselecting
thymuses expressed the same TCR but on a
RAG2
/
TAP1
/
background. In the absence of TAP, the selecting ligand is
unavailable and thymocytes do not progress beyond the DP stage.
We identified a novel gene which is upregulated in the selecting thymus
compared to its expression in the nonselecting thymus. Based on the
homology of its product to the CRPs and its specific expression in the
thymus, we named this gene the thymus LIM protein (Tlp) gene
and propose that its product is a novel member of the CRP family of
LIM-only proteins. We identified the TLP protein and showed
that, within the thymus, TLP is expressed in a unique pattern in a
subset of cTECs, most abundantly near the corticomedullary junction. To
determine the requirement for TLP in thymocyte development, we
generated mice with a targeted disruption of the Tlp locus. These mice appeared to have normal thymocyte development and thymus architecture but had a 30% decrease in thymocyte cellularity compared to littermate controls.
 |
MATERIALS AND METHODS |
Mice.
C57BL/6 mice were purchased from Jackson Laboratories
(Bar Harbor, Maine) and Taconic Farms (Germantown, N.Y.).
RAG2
/
TAP1
/
OT-1 and RAG2
/
OT-1 mice were bred in
our laboratory as previously described (37). The TCli TCR
transgenic mice (81) and the HY TCR transgenic mice
(38) have been described previously. The
TLP
/
mice were generated by targeted
disruption of the TLP locus in 129Sv embryonic stem (ES) cells
using standard methodology (see below) (61).
TLP+/
ES cells were injected into C57BL/6
blastocysts. Founder lines were established by breeding chimeric male
founders to both C57BL/6 and 129Sv females. The
TLP+/
F1 progeny were
then interbred to generate TLP+/+,
TLP+/
, and TLP
/
mice.
Targeted disruption of the TLP gene locus.
A BAC clone
containing the entire TLP gene locus was isolated from a mouse 129 genomic DNA library (Genome Systems, Inc., St. Louis, Mo.). By
restriction enzyme mapping and Southern blot analysis, a 12-kb
KpnI genomic DNA fragment containing the entire TLP coding
sequence was identified and subcloned into pBlueScript (Stratagene). A
2.1-kb fragment corresponding to the region immediately upstream of and
including the TLP gene start codon was subcloned into targeting
vector pSABGalpgkneolox2PGKDTA (a kind gift from Philippe Soriano). The
3' arm was a 3.6-kb NheI fragment of genomic DNA downstream
of the TLP gene. Two separate ES cell lines were used for the
homologous recombination: AK7 (kind gift from Philippe Soriano) and TC1
(20). ES cells were grown on mitomycin C-treated SNL
feeder cells (61) and transfected by electroporation with the linearized targeting construct DNA. Transfected cells were selected
in 300 µg of G418/ml, and colonies were isolated after 10 days of
selection. Colonies with homologous recombination were identified by
PCR using a primer annealing to a region upstream of the 5' arm
(5'CTGCTTCTACCTTCCAAGGAC3') and a primer annealing to the
-galactosidase (
-Gal) gene
(5'AGGGGACGACGACAGTATC3'). Targeted recombination resulting
in removal of TLP gene exons 1 to 8 (including the entire coding
sequence except for that encoding the first amino acid) was confirmed
by Southern blot analysis of genomic DNA.
Commercial antibodies and flow-cytometric analysis.
Conjugates of the following monoclonal Abs were purchased from
Pharmingen (San Diego, Calif.) and Caltag Laboratories (Burlingame, Calif.) and used in flow cytometry: anti-CD3
, anti-CD4, anti-CD8
, anti-CD45R (B220), anti-CD11b (Mac-1), anti-I-Ab
(MHC-II), anti-CD69, anti-CD24 (heat-stable antigen),
anti-CD11c, anti-CD80, anti-CD86, F4/80, and DEC-205. Anti-human c-myc
and horseradish peroxidase-conjugated goat anti-mouse immunoglobulin G
(IgG) and goat anti-rabbit IgG were purchased from Santa Cruz Biotechnology (Santa Cruz, Calif.). Flow cytometry of thymocytes was
performed as described previously (37).
Isolation of TLP by PCR-based subtractive hybridization and
cloning of the full-length cDNA.
Isolation of thymus RNA from mice
with selecting (Rag2
/
OT-1) or nonselecting
(Rag2
/
Tap1
/
OT-1)
thymuses, generation of cDNA, and performance of PCR-based subtractive
hybridization were as previously described (37). From this
procedure, a fragment of TLP cDNA was isolated and used to probe a
mouse thymus cDNA phage library (generously provided by James Allen).
Four independent cDNA clones were isolated, sequenced, and used to
generate a contig. The consensus sequence contained a portion of the
TLP gene open reading frame (ORF) interspersed with untranslated
sequence. We used rapid amplification of cDNA ends (Clontech, Palo
Alto, Calif.) to clone the 5' and 3' ends of the TLP gene using thymus
stromal cell cDNA and then cloned the full-length cDNA using the
following primers, in which the underlined sequences anneal to the 5'
and 3' ends, respectively, of the TLP gene:
5'AAGGATCCGCGGCCGCTGAAGAACCATGAGCTGGAC3' and 5'AAAAAACTCGAGGTCGACTTTTTGGGAATCAGTCACCATTTTA3'.
The ~1-kb PCR product was subcloned, sequenced, and found to
consist of two different cDNAs: TLP-A (965-bp) and TLP-B (1,024-bp) cDNA.
RNA isolation and Northern blot analysis.
Total RNA was
isolated using RNA STAT-60 (Tel-Test, Friendswood, Tex.), and mRNA was
prepared using a FastTrack kit (InVitrogen, Carlsbad, Calif.). Northern
blot analysis was performed essentially as described previously
(37). The probes used were fragments of or complete cDNAs
of mouse TLP, EF1
, CD4, and I-Ab (MHC-II) and
chicken GAPDH (glyceraldehyde-3-phosphate dehydrogenase). Probes were
radiolabeled using a random primer labeling kit (Invitrogen Life
Technologies) and [
-32P]dATP (Dupont,
Boston, Mass.). For the Northern analysis of thymocytes versus stromal
cells, thymocytes were dissociated from stroma by pressing a thymus
through a Nytex filter. Undissociated stromal material was collected
from inside the filter. Total RNA was isolated from the enriched
fractions. Murine cell lines used for Northern analysis were mammary
epithelial cell line C57/MG (70) and thymic epithelial
cell lines 427.1 (22), 1308.1 (22), 6.1.7 (22), Z210R.1 (24), 100.4 (22), and TE-71 (25).
Generation of anti-TLP antiserum and immunoblot analysis.
A
glutathione S-transferase (GST)-TLP fusion protein
containing TLP amino acids (aa) 78 to 115 was used to immunize New
Zealand White rabbits (R and R Rabbitry, Stanwood, Wash.). A portion of the TLP cDNA was cloned into pGEX-2T, and expression and purification of the fusion protein were performed according to the manufacturer's instructions (Pharmacia Biotech). The antiserum was affinity purified using a Sepharose column to which the GST-TLP fusion protein was coupled. To remove GST-reactive Abs, the eluate was then immunoabsorbed with GST-coupled Sepharose, and the flowthrough was used for immunoblot analysis and immunofluorescence microscopy.
Whole-cell lysates were prepared using lysis buffer (1% NP-40, 100 mM
Tris [pH 8.0], 150 mM NaCl) and quantitated by a Bradford assay.
Equal amounts of protein were loaded per lane for sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot
analysis. Each step of the immunoblot analysis was performed for 1 h at room temperature. Detection of secondary Abs was performed using
an ECL kit (Amersham, Arlington Heights, Ill.) followed by
autoradiography (Kodak, Rochester, N.Y.). Affinity-purified anti-human
c-myc and affinity-purified anti-TLP antiserum were each used at 1:100.
HRP-conjugated secondary Abs goat anti-mouse IgG and goat anti-rabbit
IgG were used at 1:1,000.
Retrovirus-mediated expression of TLP.
The Tlp
gene was cloned into the PMI vector, retroviruses were generated using
a packaging cell line, and infections were performed as previously
described (19). A 10-aa sequence (EQKLISEEDL) from human c-myc was added to the C termini of TLP-A and TLP-B by using
primers
5'TTTTTTGTCGACGAATTCTCACAGGTCCTCTTCTGAGATCAGTTTTTGTTCTTTGGATCTTATGTCCACTGGGTC3' and
5'TTTTTTG TCGACGAAT TC TCACAGG TCC TC T TC TGAGATCAG T T T T TG T TCCACCACAAGGGAGGTTGTCC3',
respectively, together with
5'AAAAAAGCGGCCGCGGAATTCACCATGAGCTGGACTTGTCCGCGTT3' in PCR.
COS cells were infected with the retrovirus containing the c-myc-tagged
versions of TLP-A and TLP-B (TLP-myc). TEC lines (427.1 and Z210R.1)
were infected with TLP-A, TLP-B, or PMI vector alone. Infected cells
were enriched by electronic sorting for cells expressing hCD2, a
reporter gene in PMI.
Immunofluorescence confocal microscopy.
Immunofluorescence
microscopy of cultured cell lines was performed essentially as
described previously (37). Uninfected and infected cells
were fixed in 4% formalin, permeabilized in 0.1% Triton X-100, and
stained using affinity-purified anti-TLP at 1:100 and
rhodamine-phalloidin (Molecular Probes, Eugene, Oreg.) at 1:600.
Fluorescein isothiocyanate (FITC)-conjugated anti-rabbit IgG was used
to visualize anti-TLP staining.
For analysis of thymus sections, immunohistochemistry was performed
essentially as described previously, with the exception
of using an
alkaline phosphatase-linked fluorescence detection
system
(
23). Briefly, thymus lobes were frozen in O.C.T. compound
(Tissue-Tek; Miles, Inc., Elkhart, Ind.) in a dry ice-ethanol
bath and
stored at

80°C. Seven-micrometer-thick cryosections
were air
dried overnight and fixed in acetone for 10 min at

20°C
prior to
staining. The primary Abs used were affinity-purified
anti-TLP at 1:100
and the rat monoclonal hybridoma supernatants
6C3 (
1),
ERTR5 (
75), and NLDC145 (
42), each at 1:1.
Visualization
of anti-TLP staining was performed using a Vectastain
ABC-AP kit
and Vector Red (Vector Laboratories, Burlingame, Calif.).
Visualization
of the rat monoclonal Abs was performed using
FITC-conjugated
goat anti-rat IgG. Levamisole (1.25 mM) was included
during incubation
with the Vector Red alkaline phosphatase to inhibit
endogenous
alkaline phosphatase activity. The stained cells and tissue
sections
were mounted and viewed by confocal microscopy using a 10×
objective
or a 40× or 100× oil lens with an MRC-1024 system (Bio-Rad,
Hercules,
Calif.) equipped with LaserSharp software and mounted on an
Axiovert
TV microscope (Carl Zeiss, Inc., Thornwood, N.Y.). Images were
electronically overlaid using Adobe Photoshop or National Instititutes
of Health Image software (public domain;
http://rsb.info.nih.gov/nih-image/download.html)
with Bio-Rad
plugins.
 |
RESULTS |
The Tlp gene is a novel LIM-only gene.
To identify
genes whose expression was regulated during thymocyte development, we
performed PCR-based subtractive hybridization using cDNA generated from
thymuses of mice in which a high degree of T-cell selection occurs
(RAG2
/
OT-1) and in which selection is
blocked at the CD4+ CD8+ DP
stage (RAG2
/
TAP1
/
OT-1). We refer to these mice as selecting and nonselecting, respectively. We used whole-thymus tissue rather than isolated thymocytes to identify genes whose expression could be developmentally regulated in thymocytes or stromal cells. In the
selecting-minus-nonselecting direction of subtraction, we cloned
a 1.3-kb RsaI fragment of TLP. In BLAST (2)
searches, this DNA fragment was not identical in sequence to any genes
in the NCBI nonredundant database but did match a small number of
mouse expressed sequence tags (ESTs) from thymus (GenBank
accession no. BF730098 and BF720933), mammary gland (GenBank accession
no. AA671952), and an eight-cell-stage embryo (GenBank accession no.
AU020984). In searching the human genome sequence, we identified eight
regions on human chromosome 6 which were 88 to 94% identical to
contiguous regions of the mouse TLP gene sequence (2).
This region on chromosome 6 is not currently assigned a gene name.
Although the matching sequence is incomplete, the high degree of
sequence identity at both the nucleotide and amino acid level suggests
that this sequence is the human homologue of the mouse TLP gene (data
not shown).
To confirm that TLP was upregulated in a selecting thymus compared to
its expression in the nonselecting thymus, we examined
expression in
C57BL/6 mice with both selecting and nonselecting
thymuses by Northern
analysis (Fig.
1). We found that TLP was
significantly upregulated in both wild-type and selecting thymuses,
compared to its expression in the nonselecting thymuses. The primary
transcript detected in each thymus sample was ~1 kb. In addition,
there was a smear of bands from 1 to 3 kb, indicative of incompletely
or alternatively spliced transcripts.

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 1.
TLP is upregulated in a selecting thymus compared to its
expression in a nonselecting thymus. Whole-thymus total RNA (10 µg)
from selecting (C57BL/6 and Rag2 / OT-1) and
nonselecting (Rag2 / Tap1 / OT-1) mice
were used for Northern analysis. The blot was probed for TLP and
normalization control EF1 .
|
|
In cloning the full-length
Tlp cDNA, two isomers (TLP-A
cDNA, 959 bp; TLP-B cDNA, 1,018 bp) were isolated with equal frequency.
The cDNAs each contained a single ORF encoding predicted proteins
of
204 and 205 aa, respectively (Fig.
2A).
We predict that the
start codon is that encoding the first Met residue
at amino acid
position 3 based on a strong Kozak sequence surrounding
it (
41)
and the presence of an in-frame stop codon
upstream. TLP-A and
TLP-B were identical from aa 1 to 185 and differed
in the remaining
C-terminal sequence.

View larger version (76K):
[in this window]
[in a new window]
|
FIG. 2.
TLP is a novel LIM-only protein closely related to the
CRPs. (A) Alignment of TLP-A, TLP-B, CRP1, CRP2, and CRP3/MLP. The
amino acid sequences were aligned using CLUSTALW (71).
Conserved amino acids are shaded: black for identical residues and gray
for similar residues. *, C and H residues of the LIM domains. The
region of TLP used to generate anti-TLP antiserum is overlined. (B)
Percentages of amino acid identity among TLP-A or -B, CRP1, CRP2, and
CRP3/MLP. (C) TLP exists as two isomers (TLP-A and TLP-B), which are
generated by alternative splicing. By aligning the sequences of two
different cDNAs encoding TLP with the genomic DNA sequence, the
structure of the TLP gene was determined. The TLP gene has eight exons
and seven introns. TLP-A and TLP-B appear to be generated due to
alternative splicing using two different splice donor sites in exon 7. The GenBank accession numbers for TLP-A and TLP-B cDNAs are AF367970
and AF367971, respectively. The GenBank accession number for the TLP
gene is AF367972.
|
|
In BLAST (
2) searches of the protein sequence database,
TLP-A and TLP-B each had the highest degree of amino acid identity
(>29%) with each of the three CRP family members: CRP1, CRP2,
and MLP
(Fig.
2A and B). TLP is not as similar in amino acid sequence
to the
CRPs as they are to each other. However, like each of the
CRP family
members, TLP has two LIM domains, each of which is
followed by a
glycine-rich region. As in the CRP family members,
the first zinc
finger within each LIM domain of TLP is of the
C-C-H-C type (Fig.
2A). The second zinc finger in each TLP LIM
domain, however, is
of the C-C-C/H-C type, differing from those
in CRP1, CRP2, and MLP and
possibly allowing it to form a different
structure by differential
chelation of the zinc
ion.
By aligning the TLP-A and TLP-B cDNA sequences to the genomic DNA
sequence, it was determined that the TLP gene spans a total
of 2.8 kb
with eight exons and seven introns. We deduced that
TLP-A and TLP-B
cDNAs were generated from alternatively spliced
transcripts using two
different splice donor sites in exon 7 (Fig.
2C).
TLP expression is thymus specific and is restricted to the stromal
compartment.
Based on Northern analysis of mRNA from several adult
mouse tissues, TLP expression appeared to be thymus specific (Fig.
3A). Since there was one mouse EST from
mammary tissue which matched the TLP sequence, we examined TLP
expression in mammary tissue isolated from an 8-week-old lactating
mouse and in mammary epithelial cell line C57 (Fig. 3B). By Northern
analysis, we were unable to detect TLP message in either mammary tissue
or the cell line, even after a long exposure.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 3.
TLP is thymus specific and is expressed only in the
stromal cell compartment. (A) Northern analysis of several adult mouse
tissues. mRNA (2 µg) harvested from whole tissue was used in Northern
analysis with probes for TLP and normalization controls GAPDH and
EF1 . sm., small; skel., skeletal. (B) Total RNA from whole thymus
(Thy; 10 µg), mammary tissue from an 8-week-old lactating mouse (20 or 50 µg, as indicated), and a mammary epithelial cell line (C57; 10 µg) was used in Northern analysis with probes for TLP and EF1 . TLP
was not detected in mammary tissue or C57 cells, even after a long
exposure. (C) mRNA (2 µg) from thymic stromal material (S) and
thymocytes (T) was used in Northern analysis with probes for TLP,
MHC-II (I-Ab), and CD4. MHC-II (not expressed in
thymocytes) and CD4 (not expressed in thymic epithelial cells)
are controls for cross contamination.
|
|
To determine in which thymus compartment TLP was expressed, we
separated thymocytes from stromal cells of a C57BL/6 mouse
thymus and
performed Northern analysis (Fig.
3C). CD4, expressed
only in
thymocytes, and MHC-II, expressed only in stromal cells,
were probed as
controls for cross contamination of RNA. TLP appeared
to be expressed
only in the stromal cells, as no TLP message was
detected in
thymocytes, even after a long exposure. We noted that
TLP message was
significantly less abundant than MHC-II, which
is expressed in the
majority of thymic epithelial cells. Based
on this expression analysis,
the TLP gene appeared to be a thymus-specific
LIM gene whose expression
is restricted to the stromal
compartment.
TLP is a 23-kDa cytoplasmic protein which does not appear to
associate with actin.
To identify the TLP protein, we raised
antibodies against a GST-TLP fusion protein containing TLP aa 78 to
115, a region between the two LIM domains (Fig. 2A). This sequence
resides in both TLP isomers and occurs in a region with little
similarity to corresponding regions of CRP1, CRP2, and MLP. The
polyclonal antiserum was affinity purified and used for immunoblot
analysis of cell lysates from COS cells, which do not express TLP, and
COS cells transfected with a C-terminal myc-tagged version of TLP
(TLP-myc) (Fig. 4). A specific band
corresponding to an apparent molecular mass of 24 kDa was detected with
the anti-TLP antiserum in transfected, but not untransfected, cells
(Fig. 4A, left). This size corresponded to the predicted size of TLP
plus the 10-aa myc tag. A band of this size was not detected using
preimmune serum from the same rabbit (data not shown). In identical
blots probed with anti-human c-myc Ab (anti-myc), a protein of the same
size was detected only in transfected COS cells (Fig. 4A, right).

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 4.
Identification of TLP. A GST-TLP fusion protein
containing TLP aa 78 to 115 (Fig. 2A) was used to immunize rabbits. The
rabbit antiserum was affinity purified and used for Western analysis.
(A) Equal amounts of whole-cell lysate prepared from control COS cells
or COS cells infected with a retrovirus encoding TLP-A (TLP-myc) were
used in SDS-PAGE and probed with either the affinity-purified anti-TLP
antiserum ( TLP) or anti-myc ( myc) on two separate blots. The
bacterially expressed GST-TLP fusion protein (1 ng) and GST protein (1 ng) were included as controls for the specificity of the antiserum. (B)
Equal amounts of extracts from thymic stromal cells (S), thymocytes
(T), and heart tissue (H) were used in SDS-PAGE and probed with
anti-TLP affinity-purified antiserum. Protein lysate from COS cells
transduced with C-terminally myc-tagged TLP (C) was used as a positive
control. The addition of the 10-aa myc tag results in a slower
migration.
|
|
To identify endogenous TLP, we used the anti-TLP antibody in an
immunoblot analysis of extracts from thymic stroma, thymocytes,
and
heart tissue (Fig.
4B). COS cells transduced with the C-terminal
myc-tagged TLP were used as a positive control. We detected a
specific
band for TLP only in the thymic stromal cells and the
positive control.
The apparent molecular mass of TLP in thymic
stroma was 23 kDa, closely
matching the predicted size. CRP1,
CRP2, and MLP are expressed in heart
(
34). The absence of TLP
in thymocytes and heart tissue
correlated with the expression
of TLP message and demonstrated the
specificity of the affinity-purified
antibody for
TLP.
Among a panel of TEC lines (427.1, 1308.1, 6.1.7, Z210R.1, 100.4, and
TE71), we were unable to identify any which endogenously
expressed TLP,
even after treatment with cytokines which induce
upregulation of MHC-II
(data not shown). To determine the subcellular
localization of TLP, we
performed immunofluorescence confocal
microscopy using TEC lines which
had been transduced with TLP
(Fig.
5).
The cells were costained for TLP and actin. In both
cortical (427.1)
and medullary (Z210R.1) TEC lines, TLP localized
to the cytoplasm. This
was also true in COS cells transduced with
TLP (data not shown). In
contrast to what has been observed for
CRP1, CRP2, and MLP, TLP did not
appear to be strongly associated
with actin, nor was there any evidence
of nuclear localization.
Thus, in epithelial cell lines, TLP is a
cytoplasmic protein of
approximately 23 kDa.

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 5.
TLP localizes to the cytoplasm in TEC lines. mTEC
(Z210R.1; A and B) and cTEC (427.1; C and D) lines were infected with a
retrovirus encoding TLP-A (A and C) or not encoding TLP-A (B and D).
Infected cells were electronically sorted on the basis of expression of
a reporter gene (hCD2), cultured, and used for immunofluorescence
confocal microscopy. After culturing, ~50% of the cells still
expressed the transduced genes as determined by hCD2 expression (data
not shown). Cells were fixed in 1% formalin-buffered saline,
permeabilized in 0.1% Triton X-100, and stained for TLP using
affinity-purified anti-TLP antiserum plus goat anti-rabbit IgG-FITC (A
to D). Infected cells were costained for actin using
phalloidin-rhodamine (A and C). Stained cells were analyzed using a
confocal microscope at 40× magnification. Similar results were
obtained using cells transduced with TLP-B (data not shown).
|
|
TLP is expressed in a subset of thymic cortical epithelial cells
near the corticomedullary junction.
To determine in which cells of
the thymic stromal compartment TLP was expressed, we performed
immunofluorescence confocal microscopy of thymus sections from a
C57BL/6 mouse (Fig. 6).
At 10× magnification, we observed scattered TLP expression in the outer cortex of the thymus and more-abundant expression of TLP in the
deep cortex, especially near the corticomedullary junction (Fig. 6A,
top). No expression of TLP was observed in the medulla (the large
aggregates of fluorescence are due to a staining artifact). The
thymuses of RAG2
/
OT-1 mice appear to have a
disorganized medullas, presumably due to the higher-than-normal degree
of selection occurring in these thymuses (12, 37). In
thymus sections from these mice there was some TLP expression in the
outer cortex but increased expression near each corticomedullary
junction (Fig. 6A, bottom). In contrast, there was little or no
staining in the RAG2
/
TAP1
/
OT-1 thymus, which does not have a
medulla (data not shown).


View larger version (181K):
[in this window]
[in a new window]
|
FIG. 6.
TLP is expressed in a subset of cTECs near the
corticomedullary junction. Cryosections (7 µm thick) of thymus from
adult mice were fixed in acetone, stained, and analyzed using a
confocal microscope. In all experiments shown, the anti-TLP antibody
was visualized using Vector Red and Vecta Stain ABC-AP (Vector
Laboratories). Cortical (C) and medullary (M) regions are indicated.
Results shown are representative of several experiments. Large
aggregates of fluorescence were sometimes observed in the medulla, even
in sections from TLP / thymus (data not shown) and are a
staining artifact. (A) C57BL/6 (top) and Rag2 / OT-1
(bottom) mouse thymus sections were stained using affinity-purified
anti-TLP antiserum (magnification, ×10). (B) Thymus sections from
C57BL/6 mice were stained with affinity-purified anti-TLP antiserum
(top) or rabbit IgG (bottom) (magnification, ×100). (C) Thymus
sections from C57BL/6 mice were costained with affinity-purified
anti-TLP antiserum and ERTR5 (top), 6C3 (middle), or NLDC145 (bottom)
(magnification, ×36). ERTR5, 6C3, and NLDC145 were visualized
with a FITC-conjugated goat anti-rat secondary Ab.
|
|
At 100× magnification of C57BL/6 mouse thymus sections, it appeared
that TLP was expressed in the stromal cells between the
densely packed
thymocytes (Fig.
6B, top). No staining was observed
when rabbit IgG was
used as the primary Ab (Fig.
6B, bottom) or
when the secondary Ab was
eliminated (data not
shown).
To assess whether TLP expression occurred in a previously defined
subpopulation of thymic stromal cells, we performed experiments
in
which we costained for TLP together with markers of known subsets
of
thymic stroma (Fig.
6C). There was no overlap between TLP and
ERTR5
(
75) (specific for medullary epithelial cells; Fig.
6C,
top). 6C3 stains a subset of thymic cortical epithelial cells
(
1). NLDC145 stains thymic DCs and a subset of cortical
epithelial
cells (
42). There was some overlap of TLP
staining with each
of these two markers (Fig.
6C, middle and bottom,
respectively),
confirming that TLP is expressed in cortical epithelial
cells.
However, there were some cells which expressed TLP but were not
positive for NLDC145 or 6C3. This was especially true for cells
near
the corticomedullary junction. Thus, TLP appears to be a
novel marker
for a subpopulation of cTECs which occur most frequently,
although not
exclusively, near the corticomedullary
junction.
Targeted disruption of TLP results in a reduction of thymus
cellularity.
To determine whether TLP was required for T-cell
development, we generated mice with a targeted disruption of the
Tlp locus (Fig. 7). The
progeny of TLP+/
intercrosses exhibited a
normal Mendelian ratio of TLP+/+,
TLP+/
, and TLP
/
mice,
indicating that TLP is not required for embryonic development (data not
shown). The TLP
/
mice produced no TLP message
in the thymus (Fig. 7C) or protein that could be detected by
immunohistochemistry (Fig. 7D). Despite this, T-cell development and
thymus architecture in the TLP
/
mice appeared
to be normal compared to those in the TLP+/+
littermate controls. There was no difference between
TLP
/
and TLP+/+ mice in
the percentages of CD4SP, CD8SP, DP, and DN subpopulations (Fig.
8A) or in the levels of surface
expression of TCR
, TCR
, CD24, CD5, and CD69 on each
thymocyte subpopulation (data not shown). Within the DN subpopulation,
there was no significant difference in the percentages of
CD44+ CD25
,
CD44+ CD25+,
CD44
CD25+, and
CD44
CD25
subpopulations (data not shown). In addition, the
TLP
/
and TLP+/+ mice
had similar percentages of peripheral CD4 and CD8 T cells. To determine
whether positive or negative selection of a limited TCR repertoire
might be affected by the absence of TLP, we bred the
TLP
/
mice to mice expressing one of various
transgenic TCRs: OT-1 (14), TCli (81), or HY
(38) (data not shown). The OT-1 and HY
transgenic TCRs are MHC-I restricted, and the TCli transgenic TCR is
MHC-II restricted. In mice bearing any one of the transgenic TCRs,
there was no difference in the degree of positive selection of
thymocytes between TLP
/
mice and
TLP+/+ littermate controls. Likewise, in HY males
there was no difference in negative selection of thymocytes between
TLP
/
mice and TLP+/+
littermate controls. Taken together, these data indicate that TLP is
not required for either positive or negative selection of T cells.


View larger version (123K):
[in this window]
[in a new window]
|
FIG. 7.
Targeted disruption of the TLP locus. (A) Schematic
diagram of the targeting construct used for generating TLP knockout
mice. Homologous recombination between the targeting construct and the
genomic TLP locus results in replacement of the entire TLP coding
sequence (open box), except the start codon, with the -Gal
gene ( gal) and a gene for neomycin resistance (neo). In the
recombinant, the TLP start codon is in frame with the -Gal ORF. ES
cells and mice with a recombinant allele were identified by PCR of the
5' end using primers annealing as shown. DTA, diphtheria toxin A gene;
*, probe for Southern analysis. (B) Southern analysis of
genomic DNA from TLP+/+, TLP+/ , and
TLP / mice. Recombination at the 3' end was confirmed by
Southern analysis of 10 µg of genomic DNA digested with
XhoI and EcoRI, using as a probe an
NheI-EcoRI fragment downstream of the
recombinant region. (C) Northern analysis of 10 µg of whole-thymus
total RNA from TLP+/+, TLP+/ , and
TLP / mice using a probe for TLP and EF1 . (D)
Immunofluorescence confocal microscopy of thymus sections from
TLP+/+ and TLP / mice. Cryosections (7 µm
thick) were costained with affinity-purified anti-TLP antiserum and
ERTR5 and analyzed as for Fig. 6C (magnification, ×36). Cortical (C)
and medullary (M) regions are indicated.
|
|

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 8.
Targeted disruption of the TLP gene results in a
decrease in thymic cellularity. Thymocytes and splenocytes from eight
pairs of TLP / and TLP+/+ littermates
(gender matched; from 3 to 26 weeks old) were counted and analyzed by
flow cytometry. (A) Averages of the percentages of four thymocyte
subpopulations (CD4SP, CD8SP, DP, and DN) expressed as ratios of
subpopulations in TLP / mice to those in
TLP+/+ mice. Error bars are standard errors of the means
(SEM). The P values are, respectively, 0.040, 0.470, 0.110, and 0.390 by the Student t test. (B) Cellularity
expressed as a ratio of the number of thymocytes or splenocytes in
TLP / mice to the number in TLP+/+ mice.
Error bars are SEM. The P values are, respectively,
0.007 and 0.270 by the Student t test.
|
|
Although T-cell selection was apparently unaffected by the absence of
TLP, there was a reduction in thymus size for
TLP
/
mice compared to that for either the
TLP
+/
or TLP
+/+
littermate controls. On average, the TLP
/
mice had 30% fewer thymocytes than the controls (Fig.
8B). This
decrease was observed in TLP
/
mice on either
a mixed C57BL/6 and 129Sv background or a pure
129Sv background.
The difference in thymic cellularity between
TLP
/
mice and littermate controls was
consistent over a wide range
of ages, from 3 to 26 weeks old. Since the
percentages of each
thymocyte subpopulation were the same for
TLP
/
and littermate controls, there was an
equivalent percent decrease
in cellularity in every subpopulation.
Despite the lower number
of thymocytes, there was no decrease in the
number of spleen cells
in TLP
/
mice (Fig.
8B).
 |
DISCUSSION |
We cloned a novel LIM-only gene which we named the Tlp
gene. TLP exists as two isomers, TLP-A and TLP-B, which are identical except for the C-terminal 19 or 20 aa. We do not know whether there is
any functional difference between the two isomers. TLP appears to be a
member of the CRP family of LIM-only proteins, based on the degree of
similarity in protein sequence and structure. Like the CRPs, TLP has
two LIM domains, each of which is followed by a glycine-rich region, a
feature unique to the CRPs (18). The LIM domains in each
of the CRPs have been shown to mediate specific protein-protein
interactions including homodimerization, association with actin
filaments, and interactions with proteins found at sites of focal
adhesion (8, 27, 64). MLP also binds to MyoD, a basic
helix-loop-helix protein critical for myogenesis (40). Such protein-protein interactions are thought to be
important both for intracellular targeting and for the formation of
multimeric protein complexes which regulate cellular differentiation
(10). TLP is likely to engage in specific protein-protein
interactions via one or both of its two LIM domains. Identification of
putative protein binding partners will be useful in understanding the
role of TLP in thymus development.
TLP is not the only LIM-only protein found in the hematopoietic system.
LMO2, also composed primarily of two LIM domains, is expressed in
erythroid precursor cells and is essential for erythroid development
(77) and adult hematopoiesis (82). Defects in
LMO2
/
mice are likely due to the loss of the
interactions of LMO2 with TAL1, a basic helix-loop-helix protein which
is also critical for erythropoiesis (72). CRIP, a LIM-only
protein with a single LIM domain, is expressed in rats primarily in
intestine but also in immune system cells, including peritoneal
macrophages and peripheral blood mononuclear cells, and in the thymus
and spleen. Although expression of CRIP has not been detected in
hematopoietic cells and tissues of mice, overexpression of CRIP under
the control of the rat CRIP promoter in mice resulted in increased
expression in the intestine, thymus, spleen, and lung, apparently
causing a 50% decrease in circulating lymphocytes (17).
TLP is, however, the first identified LIM-only protein whose expression
in the immune system is thymus specific and restricted to the stromal compartment.
We characterized the structure of the Tlp gene in mice and
found the gene to consist of eight exons and seven introns, spanning about 2.8 kb. By aligning the TLP-A and TLP-B cDNAs to the genomic sequence, we were able to determine that they are generated by alternative splicing from two different splice donor sites in exon 7 to
exon 8. By searching the human genome sequence, we identified a human
homologue for the Tlp gene. The human Tlp gene
homologue mapped to chromosome 6 and appeared to have a
structure similar to that of the Tlp gene in mice. Based on
the high degree of sequence identity, it appears that TLP is
evolutionarily conserved.
We characterized the expression of TLP by Northern analysis and
immunohistochemistry. TLP was isolated on the basis of higher expression in a selecting thymus than in a nonselecting thymus. Among a
panel of adult tissues, we detected TLP only in the thymus, and, within
the thymus, specifically in the stromal cell compartment. Despite
matching an EST from mouse mammary tissue, we were unable to detect TLP
expression in either mammary tissue or a mammary epithelial cell line.
This apparent discrepancy could be due to the fact that the
mammary-tissue source of the EST sequence was 4-week-old (prepubertal)
female mice, while our RNA sample was from an 8-week-old lactating
mouse. Alternatively, expression of TLP in mammary tissue may simply be
too low to detect by Northern analysis. TLP
/
females were fully capable of nursing their pups (data not shown). By
immunohistochemistry, TLP was expressed within the thymus in a subset
of cTECs and was most abundantly, although not exclusively, expressed
near the corticomedullary junction. This pattern of expression in the
thymus is unique. It was of particular interest because expression in
microenvironments in the cortex, especially near the corticomedullary
junction, correlated with a potential role for TLP in selection of thymocytes.
We identified the TLP protein as a 23-kDa protein which localizes to
the cytoplasm in both mTEC and cTEC lines. By immunohistochemical studies, we did not observe a strong association of TLP with actin filaments. This differs from what has been observed for CRP1, CRP2, and
MLP in colocalization studies (7, 8, 45) and suggests that
TLP has a function distinct from that of the other family members.
Interestingly, we were unable to identify any epithelial cell line with
endogenous TLP expression. It is known that expression of other genes
in TECs is dependent on close contact with thymocytes. For example,
MHC-II expression decreases dramatically within 24 h after removal
from the thymus but can be induced by the addition of cytokines. TLP
appeared to be scattered throughout the cortex of the thymus in several
foci of expressing cells, suggesting that the microenvironment may
influence TLP expression. The same cytokines that induce MHC-II,
however, did not induce expression of TLP (data not shown).
Based on the thymus-specific expression of TLP, its upregulation in a
selecting thymus compared to its expression in a nonselecting thymus,
its enriched expression in cTECs near the corticomedullary junction,
and the homology of the associated gene to a family of genes (LIM
genes) involved in development, we hypothesized that TLP was likely to
have an important role in T-cell development. To determine whether this
was the case, we generated mice with a targeted disruption of the
Tlp locus and analyzed the effect of the absence of TLP on
T-cell development. The TLP
/
mice had no
detectable message or protein. Despite extensive analysis of T-cell
subpopulations and markers of development, we were unable to identify
any defect in T-cell selection in the TLP
/
mice compared to littermate controls, in either adults or day 1 neonates. This was true even when we analyzed the effect of the
knockout in mice with a limited TCR repertoire (TCR transgenic mice).
In addition, we observed no symptoms of autoimmunity, even in older
mice (data not shown). Since the pattern of TLP expression correlated
well with a putative role in thymocyte selection, it was surprising
that there was no discernible effect on positive (or negative)
selection of thymocytes in the absence of TLP. This could be
interpreted to mean that TLP has no role in T-cell development. Alternatively, there may be redundant proteins expressed in cTECs which
were able to compensate for the loss of TLP. Although there have been
reports of low CRP1, CRP2, and MLP expression in the thymus, it is
unlikely that any of these proteins would be able to substitute for
TLP. Each CRP is only about 30% identical to TLP. In addition, TLP
does not exhibit the strong association with actin that each of the
CRPs does, suggesting a distinct role for TLP. Although TLP was
upregulated in an MHC-I-restricted selecting thymus
(Rag2
/
OT-1) compared to its expression in a
nonselecting (Rag2
/
Tap1
/
OT-1) thymus, we did not observe this
same hierarchy of expression in MHC-II-restricted selecting and
nonselecting thymuses (Rag2
/
TCli and
Rag2
/
Ii
/
TCli;
data not shown). In addition, we observed significant TLP expression in
RAG
/
and TCR
/
thymuses (by Northern analysis; data not shown), suggesting that regulation of TLP expression may be complex and not necessarily correlated with the degree of selection in all systems. The decreased expression in Rag2
/
TAP
/
OT-1 mice compared to that in
Rag2
/
OT-1 mice is not likely to be due
solely to the absence of MHC-I expression or TAP function per se, since
there was no decrease in TLP expression in
TAP
/
and
2m
/
thymuses compared to that in a C57BL/6 mouse thymus by Northern analysis (data not shown).
Although there was no apparent effect of targeted disruption of
Tlp on T-cell development, there was a significant decrease (30% ± 0.06%; n = 8, P = 0.007) in
thymic cellularity in the TLP
/
mice compared
to that in either TLP+/
or
TLP+/+ littermate controls. Despite a decrease in
the message level of TLP in TLP+/
mice, there
was no difference in cellularity between TLP+/
and TLP+/+ mice (data not shown), suggesting that
lower levels of TLP were sufficient to achieve normal cellularity. The
decrease in cellularity in TLP
/
thymuses
occurred equally in all thymic subpopulations and over a wide range of
ages (from 3 to 26 weeks), possibly reflecting a role for TLP in thymus
organogenesis. It did not appear to be the result of increased
emigration since the numbers of splenocytes in
TLP+/
mice and TLP+/+
littermate controls were the same.
Although we do not know by what mechanism deletion of TLP results in
decreased thymocyte cellularity, it is worth speculating what function
TLP may have in thymus development. Given the interdependent nature of
thymocyte and stromal cell development and the apparently normal
architecture of the TLP
/
thymus, it is
reasonable to assume that there was a similar decrease in the number of
stromal cells in TLP
/
thymuses. Decreased
stromal cellularity or a defect in normal cTEC development or
differentiation may be the direct effect of the TLP knockout, which
could, in turn, dictate the number of thymocytes which could enter or
occupy the thymus. Thus, although TLP is not required for selection of
T cells, it appears to have a role in normal thymus development.
 |
ACKNOWLEDGMENTS |
We thank Andy Farr for expert advice on immunohistochemistry
methodology. We thank the following people for helpful discussions and
critical reading of the manuscript: Kevin Urdahl, Ted Yun, Andy Farr,
and Sasha Rudensky.
Jacqueline Kirchner was supported by NIH grant AI19335.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Howard Hughes
Medical Institute and Department of Immunology, University of
Washington, Seattle, WA 98195. Phone: (206) 685-3610. Fax: (206)
685-3612. E-mail: mbevan{at}u.washington.edu.
Present address: Immunex Corporation, Seattle, WA 98101.
 |
REFERENCES |
| 1.
|
Adkins, B.,
G. F. Tidmarsh, and I. L. Weissman.
1988.
Normal thymic cortical epithelial cells developmentally regulate the expression of a B-lineage transformation-associated antigen.
Immunogenetics
27:180-186[CrossRef][Medline].
|
| 2.
|
Altschul, S. F.,
W. Gish,
W. Miller,
E. W. Myers, and D. J. Lipman.
1997.
Basic local alignment search tool.
J. Mol. Biol.
215:403-410.
|
| 3.
|
Anderson, G.,
E. J. Jenkinson,
N. C. Moore, and J. J. Owen.
1993.
MHC class II-positive epithelium and mesenchyme cells are both required for T-cell development in the thymus.
Nature
362:70-73[CrossRef][Medline].
|
| 4.
|
Anderson, G.,
N. C. Moore,
J. J. Owen, and E. J. Jenkinson.
1996.
Cellular interactions in thymocyte development.
Annu. Rev. Immunol.
14:73-99[CrossRef][Medline].
|
| 5.
|
Anderson, G.,
J. J. Owen,
N. C. Moore, and E. J. Jenkinson.
1994.
Thymic epithelial cells provide unique signals for positive selection of CD4+CD8+ thymocytes in vitro.
J. Exp. Med.
179:2027-2031[Abstract/Free Full Text].
|
| 6.
|
Anderson, M.,
S. K. Anderson, and A. G. Farr.
2000.
Thymic vasculature: organizer of the medullary epithelial compartment?
Int. Immunol.
12:1105-1110[Abstract/Free Full Text].
|
| 7.
|
Arber, S., and P. Caroni.
1996.
Specificity of single LIM motifs in targeting and LIM/LIM interactions in situ.
Genes Dev.
10:289-300[Abstract/Free Full Text].
|
| 8.
|
Arber, S.,
G. Halder, and P. Caroni.
1994.
Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation.
Cell
79:221-231[CrossRef][Medline].
|
| 9.
|
Arber, S.,
J. J. Hunter,
J. Ross,
M. Hongo,
G. Sansig,
J. Borg,
J. C. Perriard,
K. R. Chien, and P. Caroni.
1997.
MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure.
Cell
88:393-403[CrossRef][Medline].
|
| 10.
|
Bach, I.
2000.
The LIM domain: regulation by association.
Mech. Dev.
91:5-17[CrossRef][Medline].
|
| 11.
|
Boyd, R. L.,
C. L. Tucek,
D. I. Godfrey,
D. J. Izon,
T. J. Wilson,
N. J. Davidson,
A. G. Bean,
H. M. Ladyman,
M. A. Ritter, and P. Hugo.
1993.
The thymic microenvironment.
Immunol. Today
14:445-459[CrossRef][Medline].
|
| 12.
|
Brabb, T.,
E. S. Huseby,
T. M. Morgan,
D. B. Sant'Angelo,
J. Kirchner,
A. G. Farr, and J. Goverman.
1997.
Thymic stromal organization is regulated by the specificity of T cell receptor/major histocompatibility complex interactions.
Eur. J. Immunol.
27:136-146[Medline].
|
| 13.
|
Burkly, L.,
C. Hession,
L. Ogata,
C. Reilly,
L. A. Marconi,
D. Olson,
R. Tizard,
R. Cate, and D. Lo.
1995.
Expression of relB is required for the development of thymic medulla and dendritic cells.
Nature
373:531-536[CrossRef][Medline].
|
| 14.
|
Carbone, F. R.,
S. J. Sterry,
J. Butler,
S. Rodda, and M. W. Moore.
1992.
T cell receptor alpha-chain pairing determines the specificity of residue 262 within the Kb-restricted, ovalbumin257-264 determinant.
Int. Immunol.
4:861-867[Abstract/Free Full Text].
|
| 15.
|
Chisaka, O., and M. R. Capecchi.
1991.
Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5.
Nature
350:473-479[CrossRef][Medline].
|
| 16.
|
Cosgrove, D.,
S. H. Chan,
C. Waltzinger,
C. Benoist, and D. Mathis.
1992.
The thymic compartment responsible for positive selection of CD4+ T cells.
Int. Immunol.
4:707-710[Abstract/Free Full Text].
|
| 17.
|
Cousins, R. J., and L. Lanningham-Foster.
2000.
Regulation of cysteine-rich intestinal protein, a zinc finger protein, by mediators of the immune response.
J. Infect. Dis.
182(Suppl. 1):S81-S84.
|
| 18.
|
Crawford, A. W.,
J. D. Pino, and M. C. Beckerle.
1994.
Biochemical and molecular characterization of the chicken cysteine-rich protein, a developmentally regulated LIM-domain protein that is associated with the actin cytoskeleton.
J. Cell Biol.
124:117-127[Abstract/Free Full Text].
|
| 19.
|
Deftos, M. L.,
Y. W. He,
E. W. Ojala, and M. J. Bevan.
1998.
Correlating notch signaling with thymocyte maturation.
Immunity
9:777-786[CrossRef][Medline].
|
| 20.
|
Deng, C.,
A. Wynshaw-Boris,
F. Zhou,
A. Kuo, and P. Leder.
1996.
Fibroblast growth factor receptor 3 is a negative regulator of bone growth.
Cell
84:911-921[CrossRef][Medline].
|
| 21.
|
Di Santo, J. P., and H. R. Rodewald.
1998.
In vivo roles of receptor tyrosine kinases and cytokine receptors in early thymocyte development.
Curr. Opin. Immunol.
10:196-207[CrossRef][Medline].
|
| 22.
|
Faas, S. J.,
J. L. Rothstein,
B. L. Kreider,
G. Rovera, and B. B. Knowles.
1993.
Phenotypically diverse mouse thymic stromal cell lines which induce proliferation and differentiation of hematopoietic cells.
Eur. J. Immunol.
23:1201-1214[Medline].
|
| 23.
|
Farr, A.,
A. Nelson, and S. Hosier.
1992.
Characterization of an antigenic determinant preferentially expressed by type I epithelial cells in the murine thymus.
J. Histochem. Cytochem.
40:651-664[Abstract].
|
| 24.
|
Farr, A.,
A. Nelson,
S. Hosier, and A. Kim.
1993.
A novel cytokine-responsive cell surface glycoprotein defines a subset of medullary thymic epithelium in situ.
J. Immunol.
150:1160-1171[Abstract].
|
| 25.
|
Farr, A. G.,
S. Hosier,
S. C. Braddy,
S. K. Anderson,
D. J. Eisenhardt,
Z. J. Yan, and C. P. Robles.
1989.
Medullary epithelial cell lines from murine thymus constitutively secrete IL-1 and hematopoietic growth factors and express class II antigens in response to recombinant interferon-gamma.
Cell. Immunol.
119:427-444[CrossRef][Medline].
|
| 26.
|
Farr, A. G., and A. Rudensky.
1998.
Medullary thymic epithelium: a mosaic of epithelial "self"?
J. Exp. Med.
188:1-4[Free Full Text].
|
| 27.
|
Feuerstein, R.,
X. Wang,
D. Song,
N. E. Cooke, and S. A. Liebhaber.
1994.
The LIM/double zinc-finger motif functions as a protein dimerization domain.
Proc. Natl. Acad. Sci. USA
91:10655-10659[Abstract/Free Full Text].
|
| 28.
|
Fung, Y. W.,
R. X. Wang,
H. H. Heng, and C. C. Liew.
1995.
Mapping of a human LIM protein (CLP) to human chromosome 11p15.1 by fluorescence in situ hybridization.
Genomics
28:602-603[CrossRef][Medline].
|
| 29.
|
Godfrey, D. I.,
A. Zlotnik, and T. Suda.
1992.
Phenotypic and functional characterization of c-kit expression during intrathymic T cell development.
J. Immunol.
149:2281-2285[Abstract].
|
| 30.
|
Hoffmann, M. W.,
J. Allison, and J. F. Miller.
1992.
Tolerance induction by thymic medullary epithelium.
Proc. Natl. Acad. Sci. USA
89:2526-2530[Abstract/Free Full Text].
|
| 31.
|
Hollander, G. A.,
B. Wang,
A. Nichogiannopoulou,
P. P. Platenburg,
W. van Ewijk,
S. J. Burakoff,
J. C. Gutierrez-Ramos, and C. Terhorst.
1995.
Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes.
Nature
373:350-353[CrossRef][Medline].
|
| 32.
|
Hozumi, K.,
A. Kobori,
T. Sato,
H. Nozaki,
S. Nishikawa,
T. Nishimura, and S. Habu.
1994.
Pro-T cells in fetal thymus express c-kit and RAG-2 but do not rearrange the gene encoding the T cell receptor beta chain.
Eur. J. Immunol.
24:1339-1344[Medline].
|
| 33.
|
Jain, M. K.,
K. P. Fujita,
C. M. Hsieh,
W. O. Endege,
N. E. Sibinga,
S. F. Yet,
S. Kashiki,
W. S. Lee,
M. A. Perrella,
E. Haber, and M. E. Lee.
1996.
Molecular cloning and characterization of SmLIM, a developmentally regulated LIM protein preferentially expressed in aortic smooth muscle cells.
J. Biol. Chem.
271:10194-10199[Abstract/Free Full Text].
|
| 34.
|
Jain, M. K.,
S. Kashiki,
C. M. Hsieh,
M. D. Layne,
S. F. Yet,
N. E. Sibinga,
M. T. Chin,
M. W. Feinberg,
I. Woo,
R. L. Maas,
E. Haber, and M. E. Lee.
1998.
Embryonic expression suggests an important role for CRP2/SmLIM in the developing cardiovascular system.
Circ. Res.
83:980-985[Abstract/Free Full Text].
|
| 35.
|
Jiang, W.,
W. J. Swiggard,
C. Heufler,
M. Peng,
A. Mirza,
R. M. Steinman, and M. C. Nussenzweig.
1995.
The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing.
Nature
375:151-155[CrossRef][Medline].
|
| 36.
|
Karim, M. A.,
K. Ohta,
M. Egashira,
Y. Jinno,
N. Niikawa,
I. Matsuda, and Y. Indo.
1996.
Human ESP1/CRP2, a member of the LIM domain protein family: characterization of the cDNA and assignment of the gene locus to chromosome 14q32.3.
Genomics
31:167-176[CrossRef][Medline].
|
| 37.
|
Kirchner, J., and M. J. Bevan.
1999.
ITM2A is induced during thymocyte selection and T cell activation and causes downregulation of CD8 when overexpressed in CD4(+)CD8(+) double positive thymocytes.
J. Exp. Med.
190:217-228[Abstract/Free Full Text].
|
| 38.
|
Kisielow, P.,
H. S. Teh,
H. Bluthmann, and H. von Boehmer.
1988.
Positive selection of antigen-specific T cells in thymus by restricting MHC molecules.
Nature
335:730-733[CrossRef][Medline].
|
| 39.
|
Klug, D. B.,
C. Carter,
E. Crouch,
D. Roop,
C. J. Conti, and E. R. Richie.
1998.
Interdependence of cortical thymic epithelial cell differentiation and T-lineage commitment.
Proc. Natl. Acad. Sci. USA
95:11822-11827[Abstract/Free Full Text].
|
| 40.
|
Kong, Y.,
M. J. Flick,
A. J. Kudla, and S. F. Konieczny.
1997.
Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD.
Mol. Cell. Biol.
17:4750-4760[Abstract].
|
| 41.
|
Kozak, M.
1989.
Context effects and inefficient initiation at non-AUG codons in eucaryotic cell-free translation systems.
Mol. Cell. Biol.
9:5073-5080[Abstract/Free Full Text].
|
| 42.
|
Kraal, G.,
M. Breel,
M. Janse, and G. Bruin.
1986.
Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody.
J. Exp. Med.
163:981-997[Abstract/Free Full Text].
|
| 43.
|
Liebhaber, S. A.,
J. G. Emery,
M. Urbanek,
X. K. Wang, and N. E. Cooke.
1990.
Characterization of a human cDNA encoding a widely expressed and highly conserved cysteine-rich protein with an unusual zinc-finger motif.
Nucleic Acids Res.
18:3871-3879[Abstract/Free Full Text].
|
| 44.
|
Lo, D., and J. Sprent.
1986.
Identity of cells that imprint H-2-restricted T-cell specificity in the thymus.
Nature
319:672-675[CrossRef][Medline].
|
| 45.
|
Louis, H. A.,
J. D. Pino,
K. L. Schmeichel,
P. Pomies, and M. C. Beckerle.
1997.
Comparison of three members of the cysteine-rich protein family reveals functional conservation and divergent patterns of gene expression.
J. Biol. Chem.
272:27484-27491[Abstract/Free Full Text].
|
| 46.
|
Malek, T. R.,
B. O. Porter, and Y. W. He.
1999.
Multiple gamma c-dependent cytokines regulate T-cell development.
Immunol. Today
20:71-76[CrossRef][Medline].
|
| 47.
|
Markowitz, J. S.,
H. Auchincloss,
M. J. Grusby, and L. H. Glimcher.
1993.
Class II-positive hematopoietic cells cannot mediate positive selection of CD4+ T lymphocytes in class II-deficient mice.
Proc. Natl. Acad. Sci. USA
90:2779-2783[Abstract/Free Full Text].
|
| 48.
|
Marrack, P.,
D. Lo,
R. Brinster,
R. Palmiter,
L. Burkly,
R. H. Flavell, and J. Kappler.
1988.
The effect of thymus environment on T cell development and tolerance.
Cell
53:627-634[CrossRef][Medline].
|
| 49.
|
Matsuzaki, Y.,
J. Gyotoku,
M. Ogawa,
S. Nishikawa,
Y. Katsura,
G. Gachelin, and H. Nakauchi.
1993.
Characterization of c-kit positive intrathymic stem cells that are restricted to lymphoid differentiation.
J. Exp. Med.
178:1283-1292[Abstract/Free Full Text].
|
| 50.
|
McLaughlin, C. R.,
Q. Tao, and M. E. Abood.
1994.
Isolation and developmental expression of a rat cDNA encoding a cysteine-rich zinc finger protein.
Nucleic Acids Res.
22:5477-5483[Abstract/Free Full Text].
|
| 51.
|
Mombaerts, P.,
A. R. Clarke,
M. A. Rudnicki,
J. Iacomini,
S. Itohara,
J. J. Lafaille,
L. Wang,
Y. Ichikawa,
R. Jaenisch,
M. L. Hooper, et al.
1992.
Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages.
Nature
360:225-231[CrossRef][Medline].
|
| 52.
|
Moore, N. C.,
G. Anderson,
C. A. Smith,
J. J. Owen, and E. J. Jenkinson.
1993.
Analysis of cytokine gene expression in subpopulations of freshly isolated thymocytes and thymic stromal cells using semiquantitative polymerase chain reaction.
Eur. J. Immunol.
23:922-927[Medline].
|
| 53.
|
Murphy, K. M.,
A. B. Heimberger, and D. Y. Loh.
1990.
Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo.
Science
250:1720-1723[Abstract/Free Full Text].
|
| 54.
|
Naquet, P.,
M. Naspetti, and R. Boyd.
1999.
Development, organization and function of the thymic medulla in normal, immunodeficient or autoimmune mice.
Semin. Immunol.
11:47-55[CrossRef][Medline].
|
| 55.
|
Nehls, M.,
D. Pfeifer,
M. Schorpp,
H. Hedrich, and T. Boehm.
1994.
New member of the winged-helix protein family disrupted in mouse and rat nude mutations.
Nature
372:103-107[CrossRef][Medline].
|
| 56.
|
Okano, I.,
T. Yamamoto,
A. Kaji,
T. Kimura,
K. Mizuno, and T. Nakamura.
1993.
Cloning of CRP2, a novel member of the cysteine-rich protein family with two repeats of an unusual LIM/double zinc-finger motif.
FEBS Lett.
333:51-55[CrossRef][Medline].
|
| 57.
|
Oosterwegel, M. A.,
M. C. Haks,
U. Jeffry,
R. Murray, and A. M. Kruisbeek.
1997.
Induction of TCR gene rearrangements in uncommitted stem cells by a subset of IL-7 producing, MHC class-II-expressing thymic stromal cells.
Immunity
6:351-360[CrossRef][Medline].
|
| 58.
|
Palmer, D. B.,
J. L. Viney,
M. A. Ritter,
A. C. Hayday, and M. J. Owen.
1993.
Expression of the alpha beta T-cell receptor is necessary for the generation of the thymic medulla.
Dev. Immunol.
3:175-179[Medline].
|
| 59.
|
Peters, H.,
A. Neubuser,
K. Kratochwil, and R. Balling.
1998.
Pax9-deficient mice lack pharyngeal pouch derivatives and teeth and exhibit craniofacial and limb abnormalities.
Genes Dev.
12:2735-2747[Abstract/Free Full Text].
|
| 60.
|
Philpott, K. L.,
J. L. Viney,
G. Kay,
S. Rastan,
E. M. Gardiner,
S. Chae,
A. C. Hayday, and M. J. Owen.
1992.
Lymphoid development in mice congenitally lacking T cell receptor alpha beta-expressing cells.
Science
256:1448-1452[Abstract/Free Full Text].
|
| 61.
|
Ramirez-Solis, R.,
A. C. Davis, and A. Bradley.
1993.
Gene targeting in embryonic stem cells.
Methods Enzymol.
225:855-878[Medline].
|
| 62.
|
Ritter, M. A., and R. L. Boyd.
1993.
Development in the thymus: it takes two to tango.
Immunol. Today
14:462-469[CrossRef][Medline].
|
| 63.
|
Rooke, R.,
C. Waltzinger,
C. Benoist, and D. Mathis.
1999.
Positive selection of thymocytes induced by gene transfer: MHC class II-mediated selection of CD8 lineage cells.
Int. Immunol.
11:1595-1600[Abstract/Free Full Text].
|
| 64.
|
Schmeichel, K. L., and M. C. Beckerle.
1994.
The LIM domain is a modular protein-binding interface.
Cell
79:211-219[CrossRef][Medline].
|
| 65.
|
Schonrich, G.,
F. Momburg,
G. J. Hammerling, and B. Arnold.
1992.
Anergy induced by thymic medullary epithelium.
Eur. J. Immunol.
22:1687-1691[Medline].
|
| 66.
|
Shores, E. W.,
W. Van Ewijk, and A. Singer.
1991.
Disorganization and restoration of thymic medullary epithelial cells in T cell receptor-negative scid mice: evidence that receptor-bearing lymphocytes influence maturation of the thymic microenvironment.
Eur. J. Immunol.
21:1657-1661[Medline].
|
| 67.
|
Shores, E. W.,
W. Van Ewijk, and A. Singer.
1994.
Maturation of medullary thymic epithelium requires thymocytes expressing fully assembled CD3-TCR complexes.
Int. Immunol.
6:1393-1402[Abstract/Free Full Text].
|
| 68.
|
Su, D. M., and N. R. Manley.
2000.
Hoxa3 and pax1 transcription factors regulate the ability of fetal thymic epithelial cells to promote thymocyte development.
J. Immunol.
164:5753-5760[Abstract/Free Full Text].
|
| 69.
|
Surh, C. D., and J. Sprent.
1994.
T-cell apoptosis detected in situ during positive and negative selection in the thymus.
Nature
372:100-103[CrossRef][Medline].
|
| 70.
|
Telang, N. T.,
A. Suto,
G. Y. Wong,
M. P. Osborne, and H. L. Bradlow.
1992.
Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells.
J. Natl. Cancer Inst.
84:634-638[Abstract/Free Full Text].
|
| 71.
|
Thompson, J. D.,
D. G. Higgins, and T. J. Gibson.
1994.
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
Nucleic Acids Res.
22:4673-4680[Abstract/Free Full Text].
|
| 72.
|
Valge-Archer, V. E.,
H. Osada,
A. J. Warren,
A. Forster,
J. Li,
R. Baer, and T. H. Rabbitts.
1994.
The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells.
Proc. Natl. Acad. Sci. USA
91:8617-8621[Abstract/Free Full Text].
|
| 73.
|
van Ewijk, W.,
G. Hollander,
C. Terhorst, and B. Wang.
2000.
Stepwise development of thymic microenvironments in vivo is regulated by thymocyte subsets.
Development
127:1583-1591[Abstract].
|
| 74.
|
van Ewijk, W.,
B. Wang,
G. Hollander,
H. Kawamoto,
E. Spanopoulou,
M. Itoi,
T. Amagai,
Y. F. Jiang,
W. T. Germeraad,
W. F. Chen, and Y. Katsura.
1999.
Thymic microenvironments, 3-D versus 2-D?
Semin. Immunol.
11:57-64[CrossRef][Medline].
|
| 75.
|
Van Vliet, E.,
M. Melis, and W. Van Ewijk.
1984.
Monoclonal antibodies to stromal cell types of the mouse thymus.
Eur. J. Immunol.
14:524-529[Medline].
|
| 76.
|
von Freeden-Jeffry, U.,
P. Vieira,
L. A. Lucian,
T. McNeil,
S. E. Burdach, and R. Murray.
1995.
Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.
J. Exp. Med.
181:1519-1526[Abstract/Free Full Text].
|
| 77.
|
Warren, A. J.,
W. H. Colledge,
M. B. Carlton,
M. J. Evans,
A. J. Smith, and T. H. Rabbitts.
1994.
The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development.
Cell
78:45-57[CrossRef][Medline].
|
| 78.
|
Weiskirchen, R.,
M. Erdel,
G. Utermann, and K. Bister.
1997.
Cloning, structural analysis, and chromosomal localization of the human CSRP2 gene encoding the LIM domain protein CRP2.
Genomics
44:83-93[CrossRef][Medline].
|
| 79.
|
Weiskirchen, R.,
J. D. Pino,
T. Macalma,
K. Bister, and M. C. Beckerle.
1995.
The cysteine-rich protein family of highly related LIM domain proteins.
J. Biol. Chem.
270:28946-28954[Abstract/Free Full Text].
|
| 80.
|
Wiles, M. V.,
P. Ruiz, and B. A. Imhof.
1992.
Interleukin-7 expression during mouse thymus development.
Eur. J. Immunol.
22:1037-1042[Medline].
|
| 81.
|
Wong, P.,
A. W. Goldrath, and A. Y. Rudensky.
2000.
Competition for specific intrathymic ligands limits positive selection in a TCR transgenic model of CD4+ T cell development.
J. Immunol.
164:6252-6259[Abstract/Free Full Text].
|
| 82.
|
Yamada, Y.,
A. J. Warren,
C. Dobson,
A. Forster,
R. Pannell, and T. H. Rabbitts.
1998.
The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis.
Proc. Natl. Acad. Sci. USA
95:3890-3895[Abstract/Free Full Text].
|
| 83.
|
Yet, S. F.,
S. C. Folta,
M. K. Jain,
C. M. Hsieh,
K. Maemura,
M. D. Layne,
D. Zhang,
P. B. Marria,
M. Yoshizumi,
M. T. Chin,
M. A. Perrella, and M. E. Lee.
1998.
Molecular cloning, characterization, and promoter analysis of the mouse Crp2/SmLim gene. Preferential expression of its promoter in the vascular smooth muscle cells of transgenic mice.
J. Biol. Chem.
273:10530-10537[Abstract/Free Full Text].
|
Molecular and Cellular Biology, December 2001, p. 8592-8604, Vol. 21, No. 24
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.24.8592-8604.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ned, R. M., Swat, W., Andrews, N. C.
(2003). Transferrin receptor 1 is differentially required in lymphocyte development. Blood
102: 3711-3718
[Abstract]
[Full Text]